Summary
Our researchers have discovered an empirical way of preventing amyloid aggregates. They investigated CyP40 disaggregase capacity by incubating tau or a‐synuclein fibrils with purified recombinant CyP40 and found that CyP40 is capable of disrupting amyloid producing protein and preventing the accumulation of amyloid found in many neurodegenerative disorders.
This invention has great therapeutic potential to significantly arrest progression of a number of neurodegenerative diseases.
Competitive Advantages
Image shows CyP40 significantly lowered level of tau and promoted neuronal health in a mouse model overexpressing P301L tau
Desired Partnerships